A number of Facebook communities have sprung up to lend emotional and moral support to patients with diabetes, but the sites can also house questionable and biased information, report researchers at Harvard University and Brigham and Women’s Hospital.
In analyzing 15 diabetes-related Facebook sites with an average of 9,289 participants and 690 individual wall posts written by 480 users, researchers found one in four comments on the sites “were promotional in nature and generally for non-FDA approved products.”
